🕵️ Blue BIRD Corp ($BLBD)
SEC insider & ownership activity, last 12 months · CIK 1589526 · every row links its SEC filing
Over the last 12 months insiders sold $2.1M against $62K of open-market buying. Radulescu Razvan sold $1.0M (Dec–Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $62K (3 lots) · 3 sellers, $2.1M (6 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Radulescu Razvan | 0 | – | 3 | $1.0M | Feb 19, 2026 |
| Phil Horlock | 0 | – | 2 | $775K | Dec 12, 2025 |
| Sanfrey Jeffrey Scott | 0 | – | 1 | $304K | Mar 4, 2026 |
| Thau Daniel Mark | 3 | $62K | 0 | – | Aug 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 10.2% | 13G | Sep 8, 2026 | filing ↗ | |
| Abigail P. Johnson | 10.2% | 13G | Sep 8, 2026 | filing ↗ | |
| Groupe Autobus Girardin Ltee | 7.9% | 13D | Apr 1, 2026 | filing ↗ | |
| BlackRock, Inc. | 7.5% | 13G | Apr 17, 2025 | filing ↗ | |
| American Century Investment Management, Inc. | 5.6% | 13G | Feb 13, 2026 | filing ↗ | |
| American Century Companies, Inc. | 5.6% | 13G | Feb 13, 2026 | filing ↗ | |
| Stowers Institute for Medical Research | 5.6% | 13G | Feb 13, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Sanfrey Jeffrey Scott | $304K | Mar 4, 2026 | filing ↗ |
| Radulescu Razvan | $239K | Feb 19, 2026 | filing ↗ |
| Radulescu Razvan | $359K | Dec 17, 2025 | filing ↗ |
| Phil Horlock | $773K | Dec 12, 2025 | filing ↗ |
| Radulescu Razvan | $406K | Dec 10, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Material agreement (1.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 1, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Apr 1, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 1, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 11, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 15, 2026 | filing ↗ |
| Earnings (2.02) | Feb 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 24, 2025 | filing ↗ |
| Other events (8.01) | Dec 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 24, 2025 | filing ↗ |